Cryo-FIRST: Effectiveness of INTERCEPT Fibrinogen Complex (IFC) for Trauma-Associated Hemorrhage
Cryo-FIRST: Effectiveness of INTERCEPT Fibrinogen Complex (IFC) for Trauma-Associated Hemorrhage
Not yet recruiting · NCT07218185 · Registry updated 2026-06-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Cryo-FIRST: Effectiveness of INTERCEPT Fibrinogen Complex (IFC) for Trauma-Associated Hemorrhage | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, Shock, Hemorrhagic, blood coagulation disease, coagulation protein disease, congenital afibrinogenemia, hematologic disorder, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder, injury | Not yet recruiting | Not stated | 2026-06-17 | NCT07218185 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cerus Corporation | 3 |
| Coalition for National Trauma Research | 3 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Anschutz Medical Center, University of Colorado | Aurora | United States | 1 |
| Barnes Jewish Hospital, Washington University of Saint Louis | St Louis | United States | 1 |
| R Adams Cowley Shock Trauma Center, University of Maryland | Baltimore | United States | 1 |
| Ryder Trauma Center/Jackson Memorial Hospital, University of Miami | Miami | United States | 1 |